Proteasome inhibitors as potential novel anticancer agents
Authors:
- 1 August 1999
- journal article
- Published by Elsevier in Drug Resistance Updates
- Vol. 2 (4) , 215-223
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- The role of the ubiquitin-proteasome pathway in apoptosisCell Death & Differentiation, 1999
- The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappa B that blocks TNFalpha -induced apoptosisGenes & Development, 1999
- IEX -1L, an Apoptosis Inhibitor Involved in NF-κB-Mediated Cell SurvivalScience, 1998
- Cancer Cell CyclesScience, 1996
- Proteasome-Dependent Regulation of p21WAF1/CIP1ExpressionBiochemical and Biophysical Research Communications, 1996
- Enhancement of CPP32-like Activity in the TNF-Treated U937 Cells by the Proteasome InhibitorsBiochemical and Biophysical Research Communications, 1996
- Lactacystin, a Specific Inhibitor of the Proteasome, Induces Apoptosis in Human Monoblast U937 CellsBiochemical and Biophysical Research Communications, 1995
- Structure, Regulation and Function of NF-kappaBAnnual Review of Cell Biology, 1994
- Bcl-2 and the regulation of programmed cell deathJournal of Cell Biology, 1994
- Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene ProductsScience, 1990